Pre-made Fulranumab benchmark antibody ( Whole mAb, anti-NGFB/NGF therapeutic antibody, Anti-HSAN5 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Fulranumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Fulranumab is a monoclonal antibody against nerve growth factor. It was designed for the treatment of pain.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-226-1mg	1mg	3090
GMP-Bios-ab-226-10mg	10mg	Inquiry
GMP-Bios-ab-226-100mg	100mg	Inquiry
GMP-Bios-ab-226-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Fulranumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody
INN Name	Fulranumab
Target	NGF
Format	Whole mAb
Derivation	Human
Species Reactivity	Human
CH1 Isotype	IgG2
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-III
Est. Status	Discontinued
100% SI Structure	None
99% SI Structure	4m6o:HL
95-98% SI Structure	None
Year Proposed	2010
Year Recommended	2011
Companies	Janssen Pharmaceuticals;Janssen Research & Development;Takeda;Amgen
Conditions Approved	na
Conditions Active	na
Conditions Discontinued	Pain;Back pain;Cancer pain;Musculoskeletal pain;Neuropathic pain
Development Tech	Abgenix XenoMouse